Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Carew

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Cancer Research|December 17, 2005
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cellsSteffan T Nawrocki, Jennifer S Carew, Kenneth Dunner, et al.
Cancer Research|December 17, 2005
Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosisSteffan T Nawrocki, Jennifer S Carew, Maria S Pino, et al.
Diabetes Care|August 28, 2023
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD ParticipantsLeah E Cahill, Rachel A Warren, Allie S Carew, et al.
Oncogene|October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myelomaK R Kelly, C M Espitia, D Mahalingam, et al.
Irish Medical Journal|September 30, 2016
Dedicated Orthogeriatric Service Saves the HSE a Million EuroE Shanahan, C Henderson, A Butler, et al.
Clinical and Translational Discovery|August 5, 2024
Targeting autophagy: a promising approach for the treatment of breast cancer brain metastasesSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
American Journal of Preventive Cardiology|May 27, 2024
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes TrialLeah E Cahill, Rachel A Warren, Gideon D Bahn, et al.
CJC Open|June 22, 2026
Patients' Perspectives on Personalized Glycemic Targets for Coronary Artery Disease Prevention Based on the Haptoglobin Phenotype: A Qualitative StudyAllie S Carew, Robin Urquhart, Megan Aston, et al.
Leukemia|August 24, 2017
Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapyK R Kelly, C M Espitia, W Zhao, et al.
Cancer Letters|February 1, 2025
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activityJennifer S Carew, Claudia M Espitia, Sruthi Sureshkumar, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Cancer Research|December 17, 2005
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cellsSteffan T Nawrocki, Jennifer S Carew, Kenneth Dunner, et al.
Cancer Research|December 17, 2005
Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosisSteffan T Nawrocki, Jennifer S Carew, Maria S Pino, et al.
Diabetes Care|August 28, 2023
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD ParticipantsLeah E Cahill, Rachel A Warren, Allie S Carew, et al.
Oncogene|October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myelomaK R Kelly, C M Espitia, D Mahalingam, et al.
Irish Medical Journal|September 30, 2016
Dedicated Orthogeriatric Service Saves the HSE a Million EuroE Shanahan, C Henderson, A Butler, et al.
Clinical and Translational Discovery|August 5, 2024
Targeting autophagy: a promising approach for the treatment of breast cancer brain metastasesSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
American Journal of Preventive Cardiology|May 27, 2024
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes TrialLeah E Cahill, Rachel A Warren, Gideon D Bahn, et al.
CJC Open|June 22, 2026
Patients' Perspectives on Personalized Glycemic Targets for Coronary Artery Disease Prevention Based on the Haptoglobin Phenotype: A Qualitative StudyAllie S Carew, Robin Urquhart, Megan Aston, et al.
Leukemia|August 24, 2017
Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapyK R Kelly, C M Espitia, W Zhao, et al.
Cancer Letters|February 1, 2025
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activityJennifer S Carew, Claudia M Espitia, Sruthi Sureshkumar, et al.
Pageof 11